This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wentz, M. P.
Right arrow Articles by Donehower, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wentz, M. P.
Right arrow Articles by Donehower, L. A.

 Previous Article  |  Next Article 

J. Virol., 11 1997, 8542-8551, Vol 71, No. 11
Copyright © 1997, American Society for Microbiology

A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production

MP Wentz, BE Moore, MW Cloyd, SM Berget and LA Donehower
Division of Molecular Virology, Baylor College of Medicine, Houston, Texas 77030, USA.

We have isolated a naturally arising human immunodeficiency type 1 (HIV- 1) mutant containing a point mutation within the env gene. The point mutation resulted in complete loss of balanced splicing, with dominant production of aberrant mRNAs. The aberrant RNAs arose via activation of normally cryptic splice sites flanking the mutation within the env terminal exon to create exon 6D, which was subsequently incorporated in aberrant env, tat, rev, and nef mRNAs. Aberrant multiply spliced messages contributed to reduced virus replication as a result of a reduction in wild-type Rev protein. The point mutation within exon 6D activated exon 6D inclusion when the exon and its flanking splice sites were transferred to a heterologous minigene. Introduction of the point mutation into an otherwise wild-type HIV-1 proviral clone resulted in virus that was severely inhibited for replication in T cells and displayed elevated usage of exon 6D. Exon 6D contains a bipartite element similar to that seen in tat exon 3 of HIV-1, consisting of a potential exon splicing silencer (ESS) juxtaposed to a purine-rich sequence similar to known exon splicing enhancers. In the absence of a flanking 5' splice site, the point mutation within the exon 6D ESS-like element strongly activated env splicing, suggesting that the putative ESS plays a natural role in limiting the level of env splicing. We propose, therefore, that exon silencers may be a common element in the HIV-1 genome used to create balanced splicing of multiple products from a single precursor RNA.


This article has been cited by other articles:

  • Jablonski, J. A., Caputi, M. (2009). Role of Cellular RNA Processing Factors in Human Immunodeficiency Virus Type 1 mRNA Metabolism, Replication, and Infectivity. J. Virol. 83: 981-992 [Abstract] [Full Text]  
  • Jablonski, J. A., Buratti, E., Stuani, C., Caputi, M. (2008). The Secondary Structure of the Human Immunodeficiency Virus Type 1 Transcript Modulates Viral Splicing and Infectivity. J. Virol. 82: 8038-8050 [Abstract] [Full Text]  
  • Asang, C., Hauber, I., Schaal, H. (2008). Insights into the selective activation of alternatively used splice acceptors by the human immunodeficiency virus type-1 bidirectional splicing enhancer. Nucleic Acids Res 36: 1450-1463 [Abstract] [Full Text]  
  • Anderson, J. L., Johnson, A. T., Howard, J. L., Purcell, D. F. J. (2007). Both Linear and Discontinuous Ribosome Scanning Are Used for Translation Initiation from Bicistronic Human Immunodeficiency Virus Type 1 env mRNAs. J. Virol. 81: 4664-4676 [Abstract] [Full Text]  
  • Fukuhara, T., Hosoya, T., Shimizu, S., Sumi, K., Oshiro, T., Yoshinaka, Y., Suzuki, M., Yamamoto, N., Herzenberg, L. A., Herzenberg, L. A., Hagiwara, M. (2006). Utilization of host SR protein kinases and RNA-splicing machinery during viral replication. Proc. Natl. Acad. Sci. USA 103: 11329-11333 [Abstract] [Full Text]  
  • Lei, H., Vorechovsky, I. (2005). Identification of Splicing Silencers and Enhancers in Sense Alus: a Role for Pseudoacceptors in Splice Site Repression. Mol. Cell. Biol. 25: 6912-6920 [Abstract] [Full Text]  
  • Madsen, J. M., Stoltzfus, C. M. (2005). An Exonic Splicing Silencer Downstream of the 3' Splice Site A2 Is Required for Efficient Human Immunodeficiency Virus Type 1 Replication. J. Virol. 79: 10478-10486 [Abstract] [Full Text]  
  • Caputi, M., Freund, M., Kammler, S., Asang, C., Schaal, H. (2004). A Bidirectional SF2/ASF- and SRp40-Dependent Splicing Enhancer Regulates Human Immunodeficiency Virus Type 1 rev, env, vpu, and nef Gene Expression. J. Virol. 78: 6517-6526 [Abstract] [Full Text]  
  • Zahler, A. M., Damgaard, C. K., Kjems, J., Caputi, M. (2004). SC35 and Heterogeneous Nuclear Ribonucleoprotein A/B Proteins Bind to a Juxtaposed Exonic Splicing Enhancer/Exonic Splicing Silencer Element to Regulate HIV-1 tat Exon 2 Splicing. J. Biol. Chem. 279: 10077-10084 [Abstract] [Full Text]  
  • Bilodeau, P. S., Domsic, J. K., Mayeda, A., Krainer, A. R., Stoltzfus, C. M. (2001). RNA Splicing at Human Immunodeficiency Virus Type 1 3' Splice Site A2 Is Regulated by Binding of hnRNP A/B Proteins to an Exonic Splicing Silencer Element. J. Virol. 75: 8487-8497 [Abstract] [Full Text]  
  • Zheng, Z.-M., Reid, E. S., Baker, C. C. (2000). Utilization of the Bovine Papillomavirus Type 1 Late-Stage-Specific Nucleotide 3605 3' Splice Site Is Modulated by a Novel Exonic Bipartite Regulator but Not by an Intronic Purine-Rich Element. J. Virol. 74: 10612-10622 [Abstract] [Full Text]  
  • Tomonaga, K., Kobayashi, T., Lee, B. J., Watanabe, M., Kamitani, W., Ikuta, K. (2000). Identification of alternative splicing and negative splicing activity of a nonsegmented negative-strand RNA virus, Borna disease virus. Proc. Natl. Acad. Sci. USA 97: 12788-12793 [Abstract] [Full Text]  
  • Carstens, R. P., Wagner, E. J., Garcia-Blanco, M. A. (2000). An Intronic Splicing Silencer Causes Skipping of the IIIb Exon of Fibroblast Growth Factor Receptor 2 through Involvement of Polypyrimidine Tract Binding Protein. Mol. Cell. Biol. 20: 7388-7400 [Abstract] [Full Text]  
  • Jin, W., Huang, E. S.-C., Bi, W., Cote, G. J. (1999). Redundant Intronic Repressors Function to Inhibit Fibroblast Growth Factor Receptor-1 alpha -Exon Recognition in Glioblastoma Cells. J. Biol. Chem. 274: 28035-28041 [Abstract] [Full Text]  
  • Zheng, Z. M., He, P.-j., Baker, C. C. (1999). Function of a Bovine Papillomavirus Type 1 Exonic Splicing Suppressor Requires a Suboptimal Upstream 3' Splice Site. J. Virol. 73: 29-36 [Abstract] [Full Text]  
  • Del Gatto-Konczak, F., Olive, M., Gesnel, M.-C., Breathnach, R. (1999). hnRNP A1 Recruited to an Exon In Vivo Can Function as an Exon Splicing Silencer. Mol. Cell. Biol. 19: 251-260 [Abstract] [Full Text]  
  • Swanson, A. K., Stoltzfus, C. M. (1998). Overlapping Cis Sites Used for Splicing of HIV-1 env/nef and rev mRNAs. J. Biol. Chem. 273: 34551-34557 [Abstract] [Full Text]  
  • Zheng, Z. M., Huynen, M., Baker, C. C. (1998). A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly. Proc. Natl. Acad. Sci. USA 95: 14088-14093 [Abstract] [Full Text]  
  • Si, Z.-h., Rauch, D., Stoltzfus, C. M. (1998). The Exon Splicing Silencer in Human Immunodeficiency Virus Type 1 Tat Exon 3 Is Bipartite and Acts Early in Spliceosome Assembly. Mol. Cell. Biol. 18: 5404-5413 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»